Counseling on Injectable Contraception and HIV Risk in Tanzania

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Contraception
Interventions
OTHER

Counseling messages on injectable use and HIV acquisition risk

Counseling messages based on 2017 World Health Organization guidance, a review of the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-related Risks, and the Family Planning Global Handbook were provided to clients expressing interest in injectables during regular family planning appointments.

Trial Locations (10)

Unknown

Ilula Hospital, Ilula

Mafinga Hospital, Mafinga

Ihongole Health Center, Iringa

Ipogolo Health Center, Iringa

Kimande Health Center, Iringa

Ipelele Health Center, Njombe

Kibena Regional Referral Hospital, Njombe

Makambako Hospital, Njombe

Makete Hospital, Njombe

Njombe Health Center, Njombe

All Listed Sponsors
collaborator

United States Agency for International Development (USAID)

FED

collaborator

Ministry of Health, Tanzania

OTHER_GOV

collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT04160169 - Counseling on Injectable Contraception and HIV Risk in Tanzania | Biotech Hunter | Biotech Hunter